Pay in 4 interest-free payments of $7.48 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
About the GEMINI-1 Clinical Trial The GEMINI-1 clinical trial was a multi-center, randomized, double-blind, placebo-controlled Phase 3 clinical study (NCT06396429) conducted by Hengrui in China to evaluate the efficacy and safety of HRS9531 injection in adults (18 years of age) with obesity (BMI 28 kg/m 2 ) or overweight (BMI 24 kg/m 2 ) and at least one weight-related comorbidity without diabetes
A patient might make a mistake that could harm them, he said
Well-balanced treatment and study discontinuation rates compared with placebo
A TSH under 4.5uIU/mL is considered within a healthy range, but for optimal function, sometimes its best to aim for less than 2uIU/mL
If you need to lose a few pounds, break through a plateau, or get healthy and stay healthy, the program is tailored to your body and lifestyle to achieve safe and sustainable results while empowering you to maintain your progress over time
(2011) 343:d6898
US$ 29.96
US$ 26.98
US$ 25.07
US$ 23.90
